Last Update Time: 13-Mar-2025 16:00:00
ISIN: INE0O0001013
Sector: Consumer Services
Symbol: CELLPOINT

Cell Point (India) Limited

₹18.35 ₹-0.90 (-4.68%) ▼
Prev. Close ₹19.25
Open ₹19.00
Close ₹18.35
Range ₹17.43 - ₹19.27
High ₹19.00
Low ₹18.35
Ind. Close ₹0.00
VWAP ₹18.67

The current stock price of Cell Point (India) Limited is ₹18.35, with a target price range between ₹17.43 and ₹19.27. The stock has experienced a price change of ₹-0.90 (-4.68%), reflecting recent market volatility.

Today's opening price was ₹19.00, while the previous close stood at ₹19.25.

The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Cell Point (India) Limited Price Chart

Cell Point (India) Limited Pre Open Market Overview: N/A

Key Metrics:

  • IEP (Indicative Equilibrium Price): 0
  • Previous Close Price: 0
  • Change: 0.00%
  • Total Traded Volume: 0
  • Total Buy Quantity: 0
  • Total Sell Quantity: 0
PriceBuy QtySell Qty
0.000.000.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

BidQtyAskQty
0.0000.000
0.0000.000
0.0000.000
0.0000.000
0.0000.000
Total Buy Quantity: 0 Total Sell Quantity: 0

Shareholding Patterns of Cell Point (India) Limited

Key Trade Statistics of Cell Point (India) Limited

Trade InformationDetails
Traded Volume (Lakhs)0.05
Traded Value (₹ Cr.)0.01
Total Market Cap (₹ Cr.)34.29
Free Float Market Cap (₹ Cr.)9.24
Impact costN/A
Quantity Traded4,800.00
Deliverable Quantity3,600.00
% of Quantity to Traded75
Security VaRN/A
Index VaRN/A
VaR Margin50
Extreme Loss Rate3.5
Adhoc MarginN/A
Applicable Margin Rate53.5
Face Value10

Key Price Statistics of Cell Point (India) Limited

The 52-week high for Cell Point (India) Limited was ₹42.45, recorded on 12-Mar-2024. On the other hand, the 52-week low stands at ₹18.35, with the lowest value recorded on 13-Mar-2025.

The upper band for trading is ₹23.10, and the lower band is ₹15.40. The price band is 20%.

The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.05.

Price InformationDetails
52 Week High (12-Mar-2024)42.45
52 Week Low (13-Mar-2025)18.35
Upper Band23.10
Lower Band15.40
Price Band (%)20
Daily Volatility-
Annualised Volatility-
Tick Size0.05

Key Securities Statistics of Cell Point (India) Limited

Securities InformationDetails
StatusListed
Trading StatusActive
Date of Listing28-Jun-2023
Adjusted P/E149.27
Symbol P/E149.27
IndexNIFTY SME EMERGE
Macro-Economic SectorConsumer Discretionary
SectorConsumer Services
IndustryRetailing
Basic IndustrySpeciality Retail

Security Status of Cell Point (India) Limited

TitleDetails
Board StatusSME
Trading SegmentNormal Market
Session No.-
Class of SharesEquity
SDD Compliance-
Name of Compliance Officer-

Announcements of Cell Point (India) Limited

SubjectDate
Corrigendum 25-Jan-2025
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 18-Jan-2025
Structural Digital Database 17-Jan-2025
Certificate under SEBI (Depositories and Participants) Regulations, 2018 16-Jan-2025
Reply to Clarification- Financial results 26-Nov-2024
Clarification - Financial Results 14-Nov-2024
Corrigendum 02-Nov-2024
Related Party Transactions 02-Nov-2024

Corporate Actions of Cell Point (India) Limited

Face ValuePurposeEx-DateStart DateEnd Date
10ANNUAL GENERAL MEETING/DIVIDEND - RE 0.25 PER SHARE19-Sep-202420-Sep-202426-Sep-2024
10ANNUAL GENERAL MEETING22-Sep-2023--

Board Meetings of Cell Point (India) Limited

PurposeDetailsAtt.Mtg. Date
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .Board Meeting Intimation 02-Nov-2024
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2024 02-Nov-2024
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 02-Sep-2024 to consider Dividend.Board Meeting Intimation 02-Sep-2024
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 02-Sep-2024 to consider Other business.Board Meeting Intimation 02-Sep-2024
Dividend/Other business mattersTo consider dividend and consider and approve the Draft Report from Board of directors for the FY 2023-24 and other business matters 02-Sep-2024
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended March 2024 .Board Meeting Intimation 28-May-2024
Financial ResultsTo consider and approve the financial results for the period ended March 31, 2024 28-May-2024
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation 13-Nov-2023
Financial ResultsTo consider and approve the financial results for the period ended September 30, 2023 13-Nov-2023
Other business mattersTo consider other business matters: to consider and approve the Draft Board Report for the period ended on 31st March, 2023 and other items as mentioned in the Agenda 02-Sep-2023
CELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 19-Jul-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 .Board Meeting Intimation 19-Jul-2023
Other business mattersTo consider and approve the financial results for the financial results of the Company for the year ending March 31, 2023 as per Regulation 29 and 33(3)(j) of SEBI (Listing Obligations and Disclosure Requirement) Regulation 2015 and 2023 19-Jul-2023

Financial Results of Cell Point (India) Limited

Company Directory of Cell Point (India) Limited

Web AddressSM NameOfficeAddressCityPincodeTelephoneEmail
-Cell Point (India) LimitedRegistered AddressDoor No 30-15-139/F/5,6
Ward No 27, Rams Arcade,
Opposite Visakha Medical Centre,
Dabagardens, Visakhapatnam 530020
VISAKHAPATNAM - 530020
VISAKHAPATNAM
VISAKHAPATNAMN/A91-900011389cs@cellpoint.biz
-Cell Point (India) LimitedTransfer AgentS6-2, 6th Floor, Pinnacle Business Park, Mahakali
Caves Road, Next to Ahura Centre, Andheri East,
Mumbai400093
MUMBAI - 400093
MUMBAI
MUMBAIN/A022-62638200ipo@bigshareonline.com

Insider Trading of Cell Point (India) Limited

Reg. ClauseAcq./Disp.Sec. (No.)Sec. ValueTxn TypeBcast Time
No insider trading information available

Annual Reports of Cell Point (India) Limited

CompanyFrom YearTo YearAtt.
Cell Point (India) Limited20232024
Cell Point (India) Limited20222023

Investor Complaints of Cell Point (India) Limited

Event Calendar of Cell Point (India) Limited

CompanyPurposeDetailsDate
Cell Point (India) LimitedCELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .Board Meeting Intimation02-Nov-2024
Cell Point (India) LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202402-Nov-2024
Cell Point (India) LimitedCELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 02-Sep-2024 to consider Dividend.Board Meeting Intimation02-Sep-2024
Cell Point (India) LimitedCELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 02-Sep-2024 to consider Other business.Board Meeting Intimation02-Sep-2024
Cell Point (India) LimitedDividend/Other business mattersTo consider dividend and consider and approve the Draft Report from Board of directors for the FY 2023-24 and other business matters02-Sep-2024
Cell Point (India) LimitedCELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 28-May-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended March 2024 .Board Meeting Intimation28-May-2024
Cell Point (India) LimitedFinancial ResultsTo consider and approve the financial results for the period ended March 31, 202428-May-2024
Cell Point (India) LimitedCELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .Board Meeting Intimation13-Nov-2023
Cell Point (India) LimitedFinancial ResultsTo consider and approve the financial results for the period ended September 30, 202313-Nov-2023
Cell Point (India) LimitedOther business mattersTo consider other business matters: to consider and approve the Draft Board Report for the period ended on 31st March, 2023 and other items as mentioned in the Agenda02-Sep-2023
Cell Point (India) LimitedCELL POINT (INDIA) LIMITED has informed the Exchange about Board Meeting to be held on 19-Jul-2023 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2023 .Board Meeting Intimation19-Jul-2023
Cell Point (India) LimitedOther business mattersTo consider and approve the financial results for the financial results of the Company for the year ending March 31, 2023 as per Regulation 29 and 33(3)(j) of SEBI (Listing Obligations and Disclosure Requirement) Regulation 2015 and 202319-Jul-2023

Share Transfers of Cell Point (India) Limited

CompanyPeriodReg.7Reg.40Reg7 Bcast DateReg40 Bcast Date
Cell Point (India) Limited31-MAR-2024 31-May-2024 17:30:0331-May-2024 18:00:02

Voting Results of Cell Point (India) Limited

Date of Mtg.Mtg. TypeResolutionR. requiredTotal SHs% favour% against
27-SEP-2024AGMTo receive, consider and adopt the Annual Audited Standalone Financial Statements including Balance Sheet as on 31st March 2024 and Profit and Loss Account for the year ended 31st March 2024 together with the Reports the Board of Directorsᅡ﾿ and Auditorsᅡ﾿ thereonOrdinary217599.810.19
27-SEP-2024AGMAlteration of Articles of Association (Inserting a new Clause-Right to Dividend)Special21751000
27-SEP-2024AGMre-appointment of Mrs. Kiranmai Panday (DIN: 08034071), who retires by rotation and being eligible, offers herself for re-appointmentOrdinary217599.770.23
27-SEP-2024AGMdeclaration of final dividend on equity shares at the rate of 2.5% [i.e. 0.25/- (Rupees Twenty Five paisa only) per Equity Share of Face Value of Rs 10/- (Rupees Twenty Five paisa only) for the financial year ended March 31, 2024Ordinary21751000
29-SEP-2023AGMTo receive, consider and adopt the Annual Audited Standalone Financial Statements including Balance Sheet as on 31st March 2023 and Profit and Loss Account for the year ended 31st March 2023 together with the Reports the Board of Directorsᅡ﾿ and Auditorsᅡ﾿ thereonOrdinary24831000
29-SEP-2023AGM2.tRe-appointment of Statutory Auditors, M/s. RAO AND KUMAR, Chartered Accountants (Firm Registration No. 000384W), for a tenure of Next Four Financial years, from the conclusion of the 10th Annual General Meeting (ᅡ﾿AGMᅡ﾿) of the Company till the conclusion of the 14 AGM of the Company to be held in the year 2027Ordinary24831000
29-SEP-2023AGM3.tRe-appointment of MrsKirnamaiPanday ((DIN: 08034071) as a Director of the Company who retires by rotation and being eligible offers herself for reappointmentOrdinary24831000
29-SEP-2023AGM4.tIncrease in managerial remuneration of Mr. Mohan Prasad Panday, (DIN: 06493918) Managing Director of the CompanySpecial248399.960.04
29-SEP-2023AGM5.tINCREASE IN MANAGERIAL REMUNERATION OF MR. BALABALAJI PANDAY, WHOLE TIME DIRECTOR OF THE COMPANYSpecial248399.960.04
29-SEP-2023AGM6.tINCREASE IN MANAGERIAL REMUNERATION OF SMT KIRANMAI PANDAY, NON-EXECUTIVE DIRECTOR OF THE COMPANYSpecial248399.960.04

FAQs on Cell Point (India) Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.